Physician profile
Jeffrey E Caplan
NPI 1417060013
$2,661.92
in general payments reported to CMS, 2019-2025
17 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $79.82 · 2021: $232 · 2022: $824 · 2023: $432 · 2024: $788 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,332 · Education: $19.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,332.00 |
| Education | $19.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $553.10 | 2023-2024 | Novosorb Btm |
| Aroa Biosurgery Incorporated | $421.36 | 2022-2024 | |
| Integra Lifesciences Corporation | $358.34 | 2019-2022 | |
| Tela Bio, INC. | $298.87 | 2022-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Sientra, INC. | $282.40 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $213.34 | 2019-2024 | Xiaflex |
| Axogen | $155.75 | 2019-2025 | Avance Nerve Graft |
| Mentor Worldwide LLC | $151.92 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Peerless Surgical INC. | $48.22 | 2024 | |
| Abbvie INC. | $39.78 | 2024 | |
| Medtronic, INC. | $27.25 | 2022 | |
| Endo USA, INC. | $22.45 | 2024 | Xiaflex |
| Biopro, INC. | $21.40 | 2023 | |
| Amniox Medical, INC. | $20.45 | 2020 | |
| Trimed, INC. | $19.46 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $17.56 | 2019 | |
| Acell, INC. | $10.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Caplan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.